منابع مشابه
Industry Watch Medical Imaging in Drug
In our last column (PharmaGenomics 4[1], 16–19 [2004]), we began to explore the shift to a broader-than-diagnostic view of the value of imaging technologies. It stands to reason that imaging should play some broader role. After all, as Robert Dunkle reports in a recent article, “Up to 70% of the experiments in pharmaceutical research and development result in an image as an output” (1). Of cour...
متن کاملSmall animal imaging in drug development.
Better mechanistic understanding of disease through mapping of the human and mouse genomes enables rethinking of human infirmity. In the case of cancer, e.g., we may begin to associate disease states with their underlying genetic defects rather than with the organ system involved. That will enable more selective, nontoxic therapies in patients who are genetically predisposed to respond to them....
متن کاملImaging sigma receptors: applications in drug development.
Sigma receptors have been implicated in a myriad of cellular functions, biological processes and diseases. While the precise biological functions of sigma receptors have not been elucidated, recent work has shed some light on to these enigmatic systems. Sigma receptors have recently been a target of drug development related to psychiatric and neurological disorders. Sigma ligands have also been...
متن کاملA Novel Approach for Super Resolution in Medical Imaging
The recent increase in the wide use of digital imaging technologies in consumer (e.g., digital video) and other areas (e.g., security and military) has brought with it a simultaneous demand for higher-resolution images. The demand for such high-resolution (HR) images can be met by algorithmic advances in super-resolution (SR) technology intended with hardware development. Such HR images not onl...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Therapy & Oncology International Journal
سال: 2016
ISSN: 2473-554X
DOI: 10.19080/ctoij.2016.01.555565